Articles from Autonomize AI

Autonomize AI, the pioneer in empowering healthcare enterprises to become AI-native organizations, today announced the appointment of two senior leaders to its executive team: Jennifer Rouse as VP of Marketing and Gina Collins as Chief Regulatory Officer. The appointments come as Autonomize AI accelerates adoption of its governed AI platform, empowering a growing number of organizations by delivering tens of millions of dollars in general and administrative savings, measurable ROI, and industry-leading time to value.

Altais Health Solutions and Autonomize AI today announced proven, production-scale results from their strategic partnership, demonstrating how healthcare-native AI can reduce administrative burden and improve operational performance while supporting clinician-led decision-making.

Autonomize AI, a healthcare AI company pioneering enterprise-grade Agentic AI solutions, today announced its acceptance into the Microsoft for Startups Pegasus Program. The invite-only program accelerates venture-backed B2B startups through technical enablement and access to Microsoft’s global enterprise customer network.

Autonomize AI, the pioneer in agentic AI orchestration for healthcare and life sciences, announced Autonomize AI Studio and an Agent Marketplace of 100+ pre-built, healthcare-native, highly customizable AI Agents. AI Studio enables business, clinical, and IT teams to co-author, configure, and orchestrate complex operational workflows—moving from pilots to production in days, not months—with enterprise-grade governance built in. By accelerating automation across administrative and clinical workflows, Autonomize AI Agents helps organizations redirect valuable clinician and staff time back to what matters most—patients and care quality.

Autonomize AI, the pioneer in Agentic AI orchestration for healthcare and life sciences, today announced the appointment of Michele Paige and Tamara Elias, MD to its Growth Advisory Board. They join a distinguished group of leaders—including Joan Harvey, Pritesh Gandhi, MD, MPH, Anthony Nguyen, MD, MBA, and Sarah Bezerredi—who are shaping Autonomize’s strategy as the company scales its impact across health plans, providers, and pharmacy benefit management organizations.

Autonomize AI, the pioneer in Agentic AI orchestration for healthcare and life sciences, today announced the appointment of two seasoned executives to its leadership team: Scott Brennan as Head of Growth and Ujjwal Rajbhandari as Head of Solutions. Together, they bring deep expertise in AI infrastructure, cloud strategy, healthcare transformation, and business development to advance Autonomize AI’s mission of rewiring healthcare operations with accountable, human-centered AI, positioning the company to help healthcare organizations adopt accountable AI at scale.

Autonomize AI, a pioneer in AI-driven healthcare solutions, today announced that it raised $28 million in Series A funding, bringing total capital raised to $32 million to date. The round was led by Valtruis, The Cigna Group Ventures, Tau Ventures, and other strategic investors. Asset Management Ventures, ATX Venture Partners and Capital Factory are among the company’s existing investors who also participated.

Autonomize AI, a leader in trusted Generative AI for the healthcare industry announced two significant developments: the appointment of Laksh Krishnamurthy as the new Vice President of Engineering, and the achievement of SOC2 Type 2 certification.

Autonomize AI, a pioneer in AI-driven healthcare solutions, announced two key appointments to its leadership team: Jennifer Kloke, PhD, as Vice President of Artificial Intelligence (AI), and Jeffrey Eyestone as Vice President of Business Development.

Autonomize AI, a leading AI company in healthcare and life sciences, announces the appointment of Dr. Anthony Nguyen as its new Head of Strategy and Chief Medical Officer, effective December 1, 2023. This strategic addition to the team is set to accelerate the company’s endeavors in delivering AI-driven solutions for the healthcare sector, aiming to enhance patient outcomes and improve operational efficiencies.

Autonomize AI, the trusted artificial intelligence (AI) company for healthcare and life sciences, today announced it has closed a $4 million seed round to support the development and scaling of the company’s AI platform. Asset Management Ventures led the round, with participation from ATX Venture Partners, Loop Ventures and The Next Practices Group.